CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study

Shivani Handa, Yazan Madanat, Kelly Pugh, Kaitlyn Dvorak-Kornaus, Qiuhong Zhao, Alice Mims, Kristin Koenig, Andrew Srisuwananukorn, Rachel Cook, Ronan Swords, Uma Borate

Open source

DOI: 10.1016/j.bneo.2026.100274
Published: 2026-11
Container: Blood Neoplasia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.bneo.2026.100274,
  title = {CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study},
  author = {Shivani Handa and Yazan Madanat and Kelly Pugh and Kaitlyn Dvorak-Kornaus and Qiuhong Zhao and Alice Mims and Kristin Koenig and Andrew Srisuwananukorn and Rachel Cook and Ronan Swords and Uma Borate},
  year = {2026},
  journal = {Blood Neoplasia},
  doi = {10.1016/j.bneo.2026.100274},
  url = {https://doi.org/10.1016/j.bneo.2026.100274}
}

RIS

TY  - JOUR
TI  - CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study
AU  - Shivani Handa
AU  - Yazan Madanat
AU  - Kelly Pugh
AU  - Kaitlyn Dvorak-Kornaus
AU  - Qiuhong Zhao
AU  - Alice Mims
AU  - Kristin Koenig
AU  - Andrew Srisuwananukorn
AU  - Rachel Cook
AU  - Ronan Swords
AU  - Uma Borate
PY  - 2026
JO  - Blood Neoplasia
DO  - 10.1016/j.bneo.2026.100274
UR  - https://doi.org/10.1016/j.bneo.2026.100274
ER  -

APA

Handa, S., Madanat, Y., Pugh, K., Dvorak-Kornaus, K., Zhao, Q., Mims, A., Koenig, K., Srisuwananukorn, A., Cook, R., Swords, R., & Borate, U. (2026). CPX-351 in combination with ruxolitinib for advanced-phase myeloproliferative neoplasms: results of a phase 1 study. Blood Neoplasia. https://doi.org/10.1016/j.bneo.2026.100274

Source records

crossref · retrieved 2026-09-26T21:21:25.110Z